Phosphoric Acid

Phosphoric Acid

SCHEMBL8500178

CC(C)CCn1c(=O)[nH]c2nc[nH]c2c1=O.O=P(O)(O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A known ✓ P35498 1/20 0.40
SCN2A known ✓ Q99250 1/20 0.40
SCN3A known ✓ Q9NY46 1/20 0.40
ADORA2B P29275 10/20 0.64
ADORA2A P29274 7/20 0.64
ADORA3 P0DMS8 7/20 0.64
PDE4A P27815 5/20 0.64
PDE4B Q07343 5/20 0.64
PDE4C Q08493 5/20 0.64
PDE4D Q08499 5/20 0.64
PDE2A O00408 4/20 0.51
PDE1A P54750 2/20 0.51
PDE1B Q01064 2/20 0.51
PDE1C Q14123 2/20 0.51
CFTR P13569 2/20 0.42
ADORA1 P30542 2/20 0.40
PDE3A Q14432 2/20 0.40
PDE5A O76074 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL59949 0.94 ADORA2B (0.72) ADORA2BADORA2AADORA3PDE4APDE4B
Xanthine SCHEMBL692608 0.85 ADORA2B (0.61) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL5451521 0.80 ADORA2B (0.68) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL60158 0.80 ADORA2A (0.70) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL4602969 0.78 ADORA2B (0.73) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL4423680 0.78 ADORA2B (1.00) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL7326960 0.78 ADORA2A (0.67) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL27256851 0.78 ADORA2B (0.68) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL6233166 0.76 ADORA2B (1.00) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL31081359 0.76 ADORA2B (0.74) ADORA2BADORA2AADORA3PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032605-A1 METHOD FOR PRODUCING HETEROLOGOUS PROTEINS IN EUKARYOTIC CELLS ON AN INDUSTRIAL SCALE USING NUCLEOTIDE-MANIPULATING AGENTS NOVO NORDISK A/S (DK) 1999-07-01 WO disclosed